Piperacillin-tazobactam should be preferred to third-generation cephalosporins to treat wild-type inducible AmpC-producing Enterobacterales in critically ill patients with hospital or ventilator-acquired pneumonia
作者
Cédric Carrié,Guillaume Bardonneau,Laurent Petit,Alexandre Ouattara,Didier Gruson,Bruno Pereira,Matthieu Biais